Researchers test mRNA technology for universal flu vaccine
An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.
The two-dose vaccine employs the same messenger RNA (mRNA)technology used in the COVID-19 shots developed by Pfizer PFE.N with BioNTech 22UAy.DE, and by Moderna MRNA.O. It delivers tiny lipid particles containing mRNA instructions for cells to create replicas of so-called hemagglutinin proteins that appear on influenza virus surfaces.
A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.
"The idea here is to have a vaccine that will give people a baseline level of immune memory to diverse flu strains, so that there will be far less disease and death when the next flu pandemic occurs," study leader Scott Hensley of the Perelman School of Medicine at the University of Pennsylvania said in a statement.
Unlike standard flu vaccines that deliver one or two versions of hemagglutinin, the experimental vaccine includes 20 different types in the hope of getting the immune system to recognize any flu virus it might encounter in the future.
In lab experiments, vaccinated animals' immune systems recognized the hemagglutinin proteins and defended against 18 different strains of influenza A and two strains of influenza B. Antibody levels induced by the vaccine remained unchanged for at least four months, according to a report published in the journal Science.
The vaccine reduced signs of illness and protected from death even when the ferrets were exposed to a different type of flu not in the vaccine, the researchers said.
Moderna and Pfizer both have mRNA flu vaccines in late-stage human trials, and GSK GSK.L and partner CureVac 5CV.DE are testing an mRNA flu vaccine in an early-stage safety trial in humans. These vaccines are designed to defend against only four recently-circulating influenza strains but could theoretically be changed up each year.
The universal flu vaccine, if successful in human trials, would not necessarily prevent infection. The goal is to provide durable protection against severe disease and death, Hensley said.
Questions remain regarding how to judge efficacy and potential regulatory requirements for a vaccine against possible future viruses that are not currently circulating, Alyson Kelvin and Darryl Falzarano of the University of Saskatchewan, Canada, wrote in a commentary published with the study.
While the promising results with the new vaccine "suggest a protective capacity against all subtypes of influenza viruses, we cannot be sure until clinical trials in volunteers are done," Adolfo García-Sastrem, director of the Institute for Global Health and Emerging Pathogens at Mount Sinai Hospital in New York, said in a statement.
Reporting by Nancy Lapid; Editing by Christine Soares and Bill Berkrot
COVID-19 COVERAGE
CTVNews.ca Top Stories
Why wasn't the suspected Chinese spy balloon shot down over Canada?
Critics say the U.S. and Canada had ample time to shoot down a suspected Chinese spy balloon as it drifted across North America. The alleged surveillance device initially approached North America near Alaska's Aleutian Islands on Jan 28. According to officials, it crossed into Canadian airspace on Jan. 30, travelling above the Northwest Territories, Alberta and Saskatchewan before re-entering the U.S. on Jan 31.

Thieves cut huge hole in Ottawa restaurant wall to get at jewelry store next door
An Ottawa restaurateur says he was shocked to find his restaurant broken into and even more surprised to discover a giant hole in the wall that led to the neighbouring jewelry store.
Rescuers scramble in Turkiye, Syria after quake kills 4,000
Rescue workers and civilians passed chunks of concrete and household goods across mountains of rubble Monday, moving tons of wreckage by hand in a desperate search for survivors trapped by a devastating earthquake.
New details emerge ahead of Trudeau-premiers' health-care meeting
As preparations are underway for the anticipated health-care 'working meeting' between Prime Minister Justin Trudeau and Canada's premiers on Tuesday, new details are emerging about how the much-anticipated federal-provincial gathering will unfold.
Quebec minister 'surprised' asylum seekers given free bus tickets from New York City
Quebec's immigration minister says she was 'surprised' to learn the City of New York is helping to provide free bus tickets to migrants heading north to claim asylum in Canada.
The world's deadliest earthquakes since 2000
A magnitude 7.8 earthquake shook Turkiye and Syria on Monday, killing thousands of people. Here is a list of some of the world's deadliest earthquakes since 2000.
Mendicino: foreign-agent registry would need equity lens, could be part of 'tool box'
Public Safety Minister Marco Mendicino says a registry to track foreign agents operating in Canada can only be implemented in lockstep with diverse communities.
Vaccine intake higher among people who knew someone who died of COVID-19: U.S. survey
A U.S. survey found that people who had a personal connection to someone who became ill or died of COVID-19 were more likely to have received at least one shot of the vaccine compared to those who didn’t have any loved ones who had been impacted by the disease.
opinion | Don Martin: Alarms going off over health-care privatization? Such an out-of-touch waste of hot political air
The chances Trudeau's health-care summit with the premiers will end with the blueprint to realistic long-term improvements are only marginally better than believing China’s balloon was simply collecting atmospheric temperatures, Don Martin writes in an exclusive column for CTVNews.ca, 'But it’s clearly time the 50-year-old dream of medicare as a Canadian birthright stopped being such a nightmare for so many patients.'